Systems Biology in Drug Discovery and Development / Wiley Series on Technologies for the Pharmaceutical (ePub)
(Sprache: Englisch)
The first book to focus on comprehensive systems biology as applied
to drug discovery and development
Drawing on real-life examples, Systems Biology in Drug Discovery
and Development presents practical applications of systems biology
to the multiple...
to drug discovery and development
Drawing on real-life examples, Systems Biology in Drug Discovery
and Development presents practical applications of systems biology
to the multiple...
sofort als Download lieferbar
eBook (ePub)
111.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Systems Biology in Drug Discovery and Development / Wiley Series on Technologies for the Pharmaceutical (ePub)“
The first book to focus on comprehensive systems biology as applied
to drug discovery and development
Drawing on real-life examples, Systems Biology in Drug Discovery
and Development presents practical applications of systems biology
to the multiple phases of drug discovery and development. This book
explains how the integration of knowledge from multiple sources,
and the models that best represent that integration, inform the
drug research processes that are most relevant to the
pharmaceutical and biotechnology industries.
The first book to focus on comprehensive systems biology and its
applications in drug discovery and development, it offers
comprehensive and multidisciplinary coverage of all phases of
discovery and design, including target identification and
validation, lead identification and optimization, and clinical
trial design and execution, as well as the complementary systems
approaches that make these processes more efficient. It also
provides models for applying systems biology to pharmacokinetics,
pharmacodynamics, and candidate biomarker identification.
Introducing and explaining key methods and technical approaches
to the use of comprehensive systems biology on drug development,
the book addresses the challenges currently facing the
pharmaceutical industry. As a result, it is essential reading for
pharmaceutical and biotech scientists, pharmacologists,
computational modelers, bioinformaticians, and graduate students in
systems biology, pharmaceutical science, and other related
fields.
to drug discovery and development
Drawing on real-life examples, Systems Biology in Drug Discovery
and Development presents practical applications of systems biology
to the multiple phases of drug discovery and development. This book
explains how the integration of knowledge from multiple sources,
and the models that best represent that integration, inform the
drug research processes that are most relevant to the
pharmaceutical and biotechnology industries.
The first book to focus on comprehensive systems biology and its
applications in drug discovery and development, it offers
comprehensive and multidisciplinary coverage of all phases of
discovery and design, including target identification and
validation, lead identification and optimization, and clinical
trial design and execution, as well as the complementary systems
approaches that make these processes more efficient. It also
provides models for applying systems biology to pharmacokinetics,
pharmacodynamics, and candidate biomarker identification.
Introducing and explaining key methods and technical approaches
to the use of comprehensive systems biology on drug development,
the book addresses the challenges currently facing the
pharmaceutical industry. As a result, it is essential reading for
pharmaceutical and biotech scientists, pharmacologists,
computational modelers, bioinformaticians, and graduate students in
systems biology, pharmaceutical science, and other related
fields.
Autoren-Porträt von Daniel L. Young, Seth Michelson
Daniel L. Young, PhD the Director of Computational Biosciencesat Theranos Inc., where he leads the development of systems biology
approaches to advance and enhance drug discovery and development
and the optimal delivery of healthcare. He has written over twenty
publications in the field of systems biology.
Seth Michelson, PhD, is the Director of Nonclinical
Biostatistics at Genomic Health, Inc. inventor or co-inventor for
fourteen patent applications and one issued patent; and has
contributed to over seventy publications.
Bibliographische Angaben
- Autoren: Daniel L. Young , Seth Michelson
- 2011, 1. Auflage, 376 Seiten, Englisch
- Verlag: John Wiley & Sons
- ISBN-10: 1118016424
- ISBN-13: 9781118016428
- Erscheinungsdatum: 09.09.2011
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: ePub
- Größe: 5.26 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Systems Biology in Drug Discovery and Development / Wiley Series on Technologies for the Pharmaceutical"
0 Gebrauchte Artikel zu „Systems Biology in Drug Discovery and Development / Wiley Series on Technologies for the Pharmaceutical“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Systems Biology in Drug Discovery and Development / Wiley Series on Technologies for the Pharmaceutical".
Kommentar verfassen